Increased expression of the transcription factor SOX2 has been reported in a growing list of tumors, including breast, prostate, lung and in a number of highly aggressive central nervous system neoplasms, including both glioblastoma and medulloblastoma [4]–[8]. This evidence concerns the gene SOX2 and glioblastoma.